SGRP - Any uptick in business at pharmacy and grocery stores is going to benefit SGRP. Manufacturers now, more than ever, are going to be increasingly more concerned about their products selling at retail locations...which is SGRP's business And the company already had double digit growth before this corona stuff. Stock is trading for 2x EBITDA, so I guess "not horribly expensive" is an understatement.
News 
Market Data 
Discover 
